The use of liver slices from the Cape vulture (Gyps coprotheres) to better understand the role of liver toxicity of non-steroidal anti-inflammatory drugs (NSAIDs) in vultures

Loading...
Thumbnail Image

Authors

Adawaren, Emmanuel Oluwasegun
Mukandiwa, Lillian
Njoya, Emmanuel Mfotie
Bekker, Lizette
Duncan, N.M. (Neil)
Naidoo, Vinny

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Diclofenac, a non-steroidal anti-inflammatory drug (NSAID) was responsible for the death of millions of vultures on the Asian subcontinent, following the consumption of diclofenac contaminated carcasses. The aim of this research was to establish if liver slices could serve as an alternate means of predicting the toxicity of NSAIDs in Gyps vultures. The Cape vulture liver slices was prepared and incubated with four NSAIDs for 6 h. A percent clearance of 1.0 ± 0.253, 0.58 ± 0.153, 0.961 ± 0.312 and 1.242 ± 0.406 (%/h*g) was attained for diclofenac, carprofen, ketoprofen and meloxicam respectively. Both meloxicam and diclofenac exerted toxic effects on the hepatic cells. Protein content indicated that the vulture tissue had lower enzyme levels than expected for an animal of its size. The poor distinction between the ex vivo hepatic percent clearance of meloxicam and diclofenac indicates that liver slices is not an ideal model to investigate NSAIDs toxicity in Cape vulture.

Description

Keywords

Diclofenac, Meloxicam, Liver slices, Cape vulture (Gyps coprotheres), Percent clearance, Toxicity, Non-steroidal anti-inflammatory drug (NSAID)

Sustainable Development Goals

Citation

Adawaren, E.O., Mukandiwa, L., Njoya, E.M. 2018, 'The use of liver slices from the Cape vulture (Gyps coprotheres) to better understand the role of liver toxicity of non-steroidal anti-inflammatory drugs (NSAIDs) in vultures', Environmental Toxicology and Pharmacology, vol. 62, pp. 147-155.